CLIRF yields 1000000.00% · MRK yields 2.76%● Live data
📍 CLIRF pulled ahead of the other in Year 1
Combined, CLIRF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLIRF + MRK for your $10,000?
Clearford Water Systems Inc., a water management company, provides unified water infrastructure solutions in Canada, the United States, India, South America, and internationally. It operates in three segments: Waterworks, Water & Wastewater Infrastructure Delivery, and UV Pure Disinfection. The company offers Clearford One, a three-stage solution for wastewater servicing; ClearDigest, an on-site pre-treatment stage that removes solids at the source; ClearConvey, a network of small bore sewer pipes that carries liquids without any infiltration to an optimized facility for final treatment; and ClearRecover, a treatment facility. It also provides Clearford M-brane, a lifecycle solution for managed and decentralized water treatment; Clearford UV, which offers potable, wastewater, reuse, and rainwater disinfection systems; and Clearford Pay-for-Performance project financing program solutions. In addition, the company designs, manufactures, and sells ultraviolet purification systems using its patented Crossfire technology into the potable water, wastewater, reuse, and rainwater harvesting markets. Further, it provides water supply and wastewater treatment systems for small communities, as well as manufactures and supplies packaged treatment solutions, including containerized membrane plants for advanced water treatment. The company was formerly known as Clearford Industries Inc. and changed its name to Clearford Water Systems Inc. in June 2014. Clearford Water Systems Inc. is headquartered in Ottawa, Canada.
Full CLIRF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.